Minimal Residual Disease in Acute Lymphoblastic Leukemia
1 Views
administrator
06/15/23
The panelists, Raoul Tibes, MD, PhD; Stefan Faderl, MD; and Bijal D. Shah, MD, outline methods of measuring minimal residual disease and its role in the management of acute lymphoblastic leukemia.
-
Category
Show more
Facebook Comments
No comments found